World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Medicine

D-Index
139
Citations
96364
World Ranking
1724
National Ranking
63

Neil K. Aaronson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Neil K. Aaronson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 635 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Neil K. Aaronson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Neil K. Aaronson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award

Overview

Neil K. Aaronson is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. The primary field of research is Medicine, with a focus on Oncology, reflected by 96 publications in this subfield. Additional subfields of interest include Pulmonary and Respiratory Medicine, Economics and Econometrics, Pediatrics, Perinatology and Child Health, and Surgery.

The research topics explored encompass various aspects of cancer and survivorship. Main topics include:

  • Cancer survivorship and care
  • Cancer-related cognitive impairment studies
  • Childhood Cancer Survivors' Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Palliative Care and End-of-Life Issues
  • Lymphatic System and Diseases
  • Cancer Treatment and Pharmacology

Neil K. Aaronson has frequently co-authored works with the following collaborators:

  • Martijn M. Stuiver (33 publications)
  • Gabe S. Sonke (21 publications)
  • Karen Steindorf (19 publications)
  • Anne M. May (18 publications)
  • Anouk E. Hiensch (17 publications)

Key publication venues for this researcher include:

  • Supportive Care in Cancer (7 publications)
  • Journal of Cancer Survivorship (6 publications)
  • Journal of Clinical Oncology (6 publications)
  • European Journal of Cancer (5 publications)
  • Value in Health (4 publications)

Recent papers contributing to the academic literature consist of:

  • An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45, 2020, Annals of Oncology
  • Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer, 2022, European Journal of Cancer
  • Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial, 2023, The Lancet Oncology
  • Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review, 2021, Value in Health
  • A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study, 2021, The Lancet Oncology

Best Publications

  • The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

    Neil K. Aaronson;Sam Ahmedzai;Bengt Bergman;Monika Bullinger

  • Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA Project

    Barbara Gandek;John E. Ware;Neil K. Aaronson;Giovanni Apolone

  • Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations

    Neil K. Aaronson;Martin Müller;Peter D.A Cohen;Marie-Louise Essink-Bot

  • Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

    Mark R Middleton;J J Grob;N Aaronson;G Fierlbeck

  • Translating health status questionnaires and evaluating their quality: The IQOLA Project approach

    Monika Bullinger;Jordi Alonso;Giovanni Apolone;Alain Leplège

  • The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

    M. A. G. Sprangers;M. Groenvold;J. I. Arraras;J. Franklin

  • Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

    Willemien J. van Driel;Simone N. Koole;Karolina Sikorska;Jules H. Schagen van Leeuwen

  • Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project.

    Jordi Alonso;Montserrat Ferrer;Barbara Gandek;John E. Ware

  • The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review

    Mirjam A.G. Sprangers;Neil K. Aaronson;Neil K. Aaronson

  • International Quality of Life Assessment (IQOLA) Project.

    Aaronson Nk;Acquadro C;Alonso J;Apolone G

  • ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research

    Bryce B. Reeve;Kathleen W. Wyrwich;Albert W. Wu;Galina Velikova

  • Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations

    Claire F. Snyder;Neil K. Aaronson;Ali K. Choucair;Thomas E. Elliott

  • The Factor Structure of the SF-36 Health Survey in 10 Countries: Results from the IQOLA Project

    John E. Ware Jr.;Mark Kosinski;Barbara Gandek;Neil K. Aaronson

  • The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment

    John E. Ware Jr.;Barbara Gandek;Mark Kosinski;Neil K. Aaronson

  • Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

    Linda Douw;Martin Klein;Selene S. A. A. Fagel;Josje van den Heuvel

  • Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials.

    Catherine Acquadro;Katrin Conway;Asha Hareendran;Neil Aaronson

  • Developing and evaluating cross-cultural instruments from minimum requirements to optimal models

    M Bullinger;R Anderson;David Cella;N Aaronson

  • Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy

    Johannes A. Langendijk;Patricia Doornaert;Irma M. Verdonck-de Leeuw;Charles R. Leemans

  • Evaluating quality-of-life and health status instruments: development of scientific review criteria

    Kathleen N. Lohr;Neil K. Aaronson;Jordi Alonso;M. Audrey Burnam

  • Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer EDITORIAL COMMENT

    Willemien J. van Driel;Simone N. Koole;Karolina Sikorska;Jules H. Schagen van Leeuwen

Frequent Co-Authors

Peter Fayers
Peter Fayers University of Aberdeen
Mirjam A. G. Sprangers
Mirjam A. G. Sprangers University of Amsterdam
Andrew Bottomley
Andrew Bottomley European Organisation for Research and Treatment of Cancer
Morten Petersen
Morten Petersen University of Copenhagen
David Cella
David Cella Northwestern University
Martin Klein
Martin Klein Vrije Universiteit Amsterdam
Stein Kaasa
Stein Kaasa Oslo University Hospital
Johannes A. Langendijk
Johannes A. Langendijk University Medical Center Groningen
Margriet M. Sitskoorn
Margriet M. Sitskoorn Tilburg University
Jane M Blazeby
Jane M Blazeby University of Bristol

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare careers beyond traditional medicine opens up a variety of flexible online degree options. Many students consider nursing as a fulfilling and dynamic alternative. Today, you can find affordable nursing programs online, making it possible to enter the field with lower tuition costs and flexible scheduling.

Those already holding an RN license can enhance their qualifications by researching what is the cheapest rn to bsn program online, a pathway which opens doors to leadership roles and better pay. For non-nurses with a bachelor's degree in another field, entry level msn programs online provide a fast track into nursing through master’s-level studies.

For those aiming at the highest academic and clinical roles, online phd programs in nursing offer research and teaching pathways in nursing science. These diverse online options make health sciences more accessible for students seeking meaningful careers in medicine and beyond.

Best Scientists Citing Neil K. Aaronson

Trending Scientists

Recently Published Articles